FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.8750
-0.0384 (-4.20%)
May 21, 2025, 3:33 PM - Market open
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $33.48 million as of May 21, 2025. Its market cap has decreased by -87.15% in one year.
Market Cap
33.48M
Enterprise Value
34.02M
1-Year Change
-87.15%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $33.48M, a decrease of -96.46%. That is a compound annual growth rate of -92.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2025 | 34.95M | -50.19% |
| Dec 31, 2024 | 70.17M | -92.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |